Vascular Diseases Clinical Trials

58 recruiting

Vascular Diseases Trials at a Glance

426 actively recruiting trials for vascular diseases are listed on ClinicalTrialsFinder across 6 cities in 70 countries. The largest study group is Not Applicable with 175 trials, with the heaviest enrollment activity in Boston, New York, and Cleveland. Lead sponsors running vascular diseases studies include The Cleveland Clinic, Mayo Clinic, and Insel Gruppe AG, University Hospital Bern.

Browse vascular diseases trials by phase

Treatments under study

About Vascular Diseases Clinical Trials

Looking for clinical trials for Vascular Diseases? There are currently 58 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Vascular Diseases trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Vascular Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 426 trials

Recruiting

Natural History of Stroke: Cause and Development

Brain DiseaseVascular DiseasesIschemic Attack, Transient+2 more
National Institute of Neurological Disorders and Stroke (NINDS)4,000 enrolled3 locationsNCT00009243
Recruiting

Diabetes and Heart Disease Risk in Blacks

ObesityCardiovascular DiseasesHypertension+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2,000 enrolled1 locationNCT00001853
Recruiting

Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke

StrokeBrain DiseaseVascular Diseases+1 more
National Institute of Neurological Disorders and Stroke (NINDS)450 enrolled1 locationNCT06615973
Recruiting

Hypertension Explored in Long-term Postpartum Follow-up in Later Life

Cardiovascular DiseasesHypertensionCerebrovascular Disorders+1 more
University of Oxford200 enrolled1 locationNCT06187012
Recruiting
Phase 3

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Cardiovascular DiseasesHypertensionDiabetes Mellitus, Type 2
Boehringer Ingelheim11,800 enrolled1152 locationsNCT07064473
Recruiting
Not Applicable

SMART to Optimize an Intervention to Maintain Health Improvements After Cardiac Rehabilitation

Cardiovascular DiseasesCardiac Rehabilitation
The Miriam Hospital400 enrolled1 locationNCT06886789
Recruiting

Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa

ObesityCardiovascular DiseasesChronic Kidney Diseases+8 more
Swiss Tropical & Public Health Institute1,200 enrolled1 locationNCT05881447
Recruiting

Cardiovascular Health Improvement Project

Heart FailureCardiovascular DiseasesAortic Aneurysm+2 more
University of Michigan15,000 enrolled1 locationNCT02306200
Recruiting

Identifying Risk Factors and Predicting Future Health Outcomes for Korean Patients With Heart and Blood Vessel Diseases: A Long-term Follow-up Study

Cardiovascular Diseases (CVD)Cerebro Vascular Disease
Samsung Medical Center800,000 enrolled1 locationNCT07393412
Recruiting

Mayo AVC Registry and Biobank

CardiomyopathiesCardiovascular DiseasesHeart Diseases+5 more
Mayo Clinic1,000 enrolled2 locationsNCT03049254
Recruiting

Fascial Plane Blocks and Quality of Recovery in Cardiac Surgery

Pain, PostoperativeCardiovascular DiseasesCardiovascular Surgical Procedures
Ordu University123 enrolled1 locationNCT07557108
Recruiting

Pivotal Study for the Cardiac Performance System (CPS)

Cardiovascular Diseases
Sensydia Corporation1,000 enrolled10 locationsNCT06870591
Recruiting

Longitudinal Real-world Clinical Outcomes Study on Symplicity Renal Denervation

Cardiovascular DiseasesHypertensionVascular Diseases
Medtronic Vascular1,000 enrolled1 locationNCT07174622
Recruiting

Study on Construction of Whole Lifecycle Cohort, Big Data Management and Clinical Prognosis of Cardio-Renal-Metabolic (CKM) Syndrome

Chronic Kidney DiseaseMetabolic DiseasesCardiovascular Diseases (CVD)
First Affiliated Hospital of Fujian Medical University8,000 enrolled1 locationNCT07547098
Recruiting
Phase 2

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Cardiovascular DiseasesFibrosisLung Diseases+3 more
Pulmovant, Inc.20 enrolled1 locationNCT07333183
Recruiting

Medtronic SYMBIOSIS Post-Market Registry for Patients Undergoing Cardiac Surgery

Cardiovascular Diseases
Medtronic Cardiac Surgery5,000 enrolled14 locationsNCT04241328
Recruiting
Not Applicable

The Prevalence, Disease Burden and Prognosis of COPD in Patients With Cardiovascular Diseases

Cardiovascular Diseases
AstraZeneca3,000 enrolled84 locationsNCT06909773
Recruiting

Comparing Traditional Risk Scores and an AI-Based Multimodal Model for Predicting Cardiovascular Events After Gastrointestinal Surgery

Cardiovascular DiseasesPostoperative ComplicationsDigestive System Surgical Procedures
Bach Mai Hospital5,000 enrolled1 locationNCT07539532
Recruiting

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature

Peripheral Vascular Diseases
Boston Scientific Corporation5,000 enrolled79 locationsNCT04674969
Recruiting

DeBakey Cardiovascular Magnetic Resonance Study

Cardiovascular Diseases
Dipan Shah100,000 enrolled1 locationNCT04281823